Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Critical Care Physicians (US)(?)

Council Members in this Study Group: 54

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

What is a GLG Leader?
Jason Campagna, MD,PhD, Director of Clinical Quality and Analytics, Cottage Health SystemJason Campagna, MD,PhD
Director of Clinical Quality and Analytics
Cottage Health System

Jason Campagna, MD, PhD, is an Anesthesiologist at Anesthesia Medical Group of Santa Barbara in California. He is also Director of Center for Clinical Quality and Analytics at Cottage Health System, an Adjunct Professor of neuroscience and serves as the Director of Center for Applied Neurosciences...

GLG NewsSMAnalyses by this Study Group's Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
The Pleitropic Effects of Volatile Anesthetics: Pain and Inhaled Agents? | 07-02-2008
Analysis of: Why anaesthetics can make the pain worse | www.newscientist.com
Author: Jason Campagna, MD,PhD, Director of Clinical Quality and Analytics, Cottage Health System

There are well over 70 Million general anesthetics performed in the US each year, and the majority of these utilize one of four generally used inhaled anesthetic agents (Sevoflurane, Desflurane, Isoflurane and Halothane). How these drugs act to produce "unconsciousness" is largely unknown, but as the...

Improving anesthetic/surgical outcomes- the role of pharmacoprophylaxis | 05-19-2008
Author: GLG Expert Contributor

To most in anesthesia, a "good anesthetic" is when the patient is delivered to the post anesthesia care unit in a stable fashion.  However, it may be more complicated and success is determined by 30-180 day markers of myocardial or CNS morbidity.  Unfortunately, this type of followup is not...

Aspect Medical Systems in the Spotlight- The Bis Monitor, Medical Need and The Capital Markets | 03-28-2008
Analysis of: Anesthesia Awareness and the Bispectral Index | content.nejm.org
Author: Jason Campagna, MD,PhD, Director of Clinical Quality and Analytics, Cottage Health System

1. The market for "depth of anesthesia" monitors has depended very much on marketing and public perception of the problem. This article shines a bright light on the more objective issues of utility and efficacy. 2. Aspect Medical has made a number of mis-steps over the years that have alienated them...

The impact in disease prevention efforts is how you identify root problems | 12-06-2007
Author: GLG Expert Contributor

Medicare and Medicaid today are predominantly reactive disease diagnosis and management programs, usually in late stages. That form of care leads to the significant growth of healthcare expenditure (currently estimated at 8% GDP). The future of cost control is disease prevention. Many diseases are only...

The impact of HSD1 inhibitor on decreasing diabetes, hypertension, obesity, heart disease and their complications | 10-29-2007
Author: GLG Expert Contributor

The development of HSD1 inhibitors respresents a promising advance in managing diabetes and the metabolic syndrome comprising of obesity, hypertension, and difficult regulation of serum glucose levels. Control of the problems of diabetes and the metabolic syndrome would compose the major components...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Academic Institution*
  • Other Freestanding Healthcare Facility

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Department Chair
  • Professor
  • Medical Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics